Comarest 50 μg Ophthalmic Solution
PDF Leaflet Revision Date: 20 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of elevated intraocular pressure in glaucoma and ocular hypertension.
Dosage (summary)
One drop in the affected eye(s) once daily, preferably in the evening.
Onset of Action / Duration
Onset: 3-4 hours, Duration: 24 hours
Special Populations
- Children under 3 years
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Additive effect with beta-blockers
- Avoid multiple prostaglandin analogues
Contraindications
- Hypersensitivity to latanoprost or excipients
- Pregnancy
- Lactation
Common side effects
- Iris hyperpigmentation
- Eye irritation
- Eyelash changes
Counselling Points
- Remove contact lenses before use
- May cause transient blurring of vision
Serious warnings
- Potential for permanent eye color change
- Caution in patients with herpetic keratitis
Important Disclaimer
The Comarest 50 μg Ophthalmic Solution professional information leaflet below is the property of Ipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
